It has emerged as a promising approach in AD as it offers the possibility of having two pieces of information (neurodegeneration as perfusion and amyloid/tau pathological information depending on the tracer) with a single tracer injection.57 The gene discussed is MAPT; the disease is Alzheimer disease.